| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w22277 |
| 来源ID | Working Paper 22277 |
| Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D | |
| Liran Einav; Amy Finkelstein; Maria Polyakova | |
| 发表日期 | 2016-05-23 |
| 出版年 | 2016 |
| 语种 | 英语 |
| 摘要 | Standard theory suggests that optimal consumer cost-sharing in health insurance increases with the price elasticity of demand, yet publicly-provided drug coverage typically involves uniform cost-sharing across drugs. We investigate how private drug plans set cost-sharing in the context of Medicare Part D. We document substantial heterogeneity in the price elasticities of demand across more than 150 drugs and across more than 100 therapeutic classes, as well as substantial heterogeneity in the cost-sharing for different drugs within privately-provided plans. We find that private plans set higher consumer cost-sharing for drugs or classes with more elastic demand. Our findings suggest that benefit design may be more efficient in privately rather than publicly provided insurance. |
| 主题 | Microeconomics ; Households and Firms ; Financial Economics ; Financial Institutions ; Public Economics ; National Fiscal Issues ; Health, Education, and Welfare ; Health |
| URL | https://www.nber.org/papers/w22277 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/579949 |
| 推荐引用方式 GB/T 7714 | Liran Einav,Amy Finkelstein,Maria Polyakova. Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D. 2016. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w22277.pdf（850KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
